Results 151 to 160 of about 165,866 (292)
ABSTRACT Background Large type III gastric cancer (GC) ≥ 8 cm has conventionally been categorized with type IV GC in Japan, leading to alternative treatment strategies such as neoadjuvant chemotherapy and staging laparoscopy (SL). However, whether 8 cm is the correct cutoff remains unclear.
Yutaka Sugita +8 more
wiley +1 more source
Machine learning in gastrointestinal endoscopy: challenges and opportunities. [PDF]
Lobanovs S +5 more
europepmc +1 more source
This study introduces the non‐flap tunnel technique (NFTT) as a simplified method for esophagogastrostomy following minimally invasive proximal gastrectomy. Compared with the conventional double‐flap technique, NFTT significantly reduces reconstruction time and the incidence of anastomotic stenosis, while maintaining comparable anti‐reflux outcomes ...
Masaru Hayami +6 more
wiley +1 more source
A rare case of giant fibrovascular polyp endoscopically resected with loop and cut technique
Benedetto Mangiavillano, MD +4 more
doaj +1 more source
Impact of social-psychological factors on anxiety before gastrointestinal endoscopy and quality of life. [PDF]
Huang ZP +6 more
europepmc +1 more source
Essential Updates 2023/2024: Minimally Invasive Surgery for Biliary Tract Cancer
ABSTRACT Minimally invasive surgery (MIS) for biliary tract cancer (BTC) has gained traction with advancements in laparoscopic and robotic techniques. However, its oncological impact remains uncertain. This review highlights key studies from 2023 and 2024 on MIS for BTC, including distal bile duct, hilar bile duct, gallbladder, and intrahepatic bile ...
Osamu Itano, Takuya Minagawa
wiley +1 more source
Endoscopy training: Indian perspective
M. K. Goenka +3 more
doaj +1 more source
ABSTRACT Background Although surgical treatment is the primary measure for patients with perforated peptic ulcer (PPU), nonoperative management (NOM) has become a common alternative. However, risk score models predicting the success of NOM based on the analysis of a large number of patients remain scarce.
Kei Ito +12 more
wiley +1 more source

